Editorial

Paediatric inflammatory multisystem syndrome: What should we look out for in South Africa?

Bookmark and Share
C L Hendricks, F Mustafa, R J Green, M S Pepper

Authors' affiliations

C L Hendricks, Institute for Cellular and Molecular Medicine, Department of Immunology, Faculty of Health Sciences, University of Pretoria, South Africa; SAMRC Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, South Africa

F Mustafa, Institute for Cellular and Molecular Medicine, Department of Immunology, Faculty of Health Sciences, University of Pretoria, South Africa; SAMRC Extramural Unit for Stem Cell Research and Therapy; Department of Paediatrics and Child Health, Faculty of Health Sciences, University of Pretoria, South Africa

R J Green, Department of Paediatrics and Child Health, Faculty of Health Sciences, University of Pretoria, South Africa

M S Pepper, Institute for Cellular and Molecular Medicine, Department of Immunology, Faculty of Health Sciences, University of Pretoria, South Africa; SAMRC Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, South Africa

Full Text

PDF (107KB)

Keywords

Paediatric inflammatory multisystem syndrome; South Africa; Children; COVID-19; Acute respiratory distress syndrome; ARDS

Cite this article

South African Medical Journal 2020;110(9):832-834. DOI:10.7196/SAMJ.2020.v110i9.15062

Article History

Date submitted: 2020-08-31
Date published: 2020-08-31

Article Views

Abstract views: 1415
Full text views: 1543

Comments on this article

*Read our policy for posting comments here